Operating Margin of Apellis Pharmaceuticals, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Apellis Pharmaceuticals, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Apellis Pharmaceuticals, Inc. Operating Margin for the quarter ending 30 Sep 2025 was 8%.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2024 was -21%, a 84% increase from 2023.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2023 was -130%, a 83% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Operating Margin for 2022 was -788%, a 2.1% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 8% +39% 01 Jul 2025 30 Sep 2025
Q2 2025 -25% +25% +49% 01 Apr 2025 30 Jun 2025
Q1 2025 -24% +53% +69% 01 Jan 2025 31 Mar 2025
Q4 2024 -21% +109% +84% 01 Oct 2024 31 Dec 2024
Q3 2024 -31% +187% +86% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% +282% +85% 01 Apr 2024 30 Jun 2024
Q1 2024 -77% +528% +87% 01 Jan 2024 31 Mar 2024
Q4 2023 -130% +658% +83% 01 Oct 2023 31 Dec 2023
Q3 2023 -219% 01 Jul 2023 30 Sep 2023
Q2 2023 -332% 01 Apr 2023 30 Jun 2023
Q1 2023 -605% 01 Jan 2023 31 Mar 2023
Q4 2022 -788% 01 Oct 2022 31 Dec 2022

Apellis Pharmaceuticals, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -21% +109% +84% 01 Jan 2024 31 Dec 2024
2023 -130% +658% +83% 01 Jan 2023 31 Dec 2023
2022 -788% +17% +2.1% 01 Jan 2022 31 Dec 2022
2021 -806% -720% -845% 01 Jan 2021 31 Dec 2021
2020 -85% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.